We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
-5.8%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$17.9B
AUM Growth
-$2.38B
(-12%)
Cap. Flow
-$772M
Cap. Flow
% of AUM
-4.31%
Top 10 Holdings %
Top 10 Hldgs %
23.3%
Holding
1,751
New
15
Increased
221
Reduced
786
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verra Mobility
VRRM
|
+$34.1M |
| 2 |
S&P Global
SPGI
|
+$22.9M |
| 3 |
Quanta Services
PWR
|
+$22M |
| 4 |
NOVA
Sunnova Energy
NOVA
|
+$20.8M |
| 5 |
Johnson Controls International
JCI
|
+$19.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LTHM
Livent Corporation
LTHM
|
+$54.7M |
| 2 |
IPG Photonics
IPGP
|
+$48.9M |
| 3 |
Darling Ingredients
DAR
|
+$46.6M |
| 4 |
NVIDIA
NVDA
|
+$45.2M |
| 5 |
Amazon
AMZN
|
+$38.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.99% |
| 2 | Healthcare | 18.87% |
| 3 | Consumer Discretionary | 13.32% |
| 4 | Financials | 12.03% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KYNB
1551
Kyntra Bio
KYNB
$28.7M
| $274K | ﹤0.01% |
912
| – | – |
|
1552
Gevo
GEVO
$391M
| $273K | ﹤0.01% |
58,300
| – | – |
|
1553
National Beverage
FIZZ
$2.9B
| $272K | ﹤0.01% |
6,258
| – | – |
|
|
EBIX
1554
DELISTED
Ebix Inc
EBIX
| $271K | ﹤0.01% |
8,165
| – | – |
|
1555
Blink Charging
BLNK
$85.6M
| $270K | ﹤0.01% |
10,200
| – | – |
|
1556
Conduent
CNDT
$241M
| $270K | ﹤0.01% |
52,399
| – | – |
|
1557
The GEO Group
GEO
$4.14B
| $270K | ﹤0.01% |
40,900
| – | – |
|
|
GES
1558
DELISTED
Guess Inc
GES
| $270K | ﹤0.01% |
12,374
-6,600
| -35% | -$143K |
|
|
HAPN
1559
Happen Inc
HAPN
$2.25B
| $270K | ﹤0.01% |
17,100
-1,600
| -9% | -$29.6K |
|
1560
Pacific Biosciences
PACB
$345M
| $268K | ﹤0.01% |
29,400
-10,900
| -27% | -$125K |
|
1561
Arcus Biosciences
RCUS
$3.69B
| $268K | ﹤0.01% |
8,500
-3,800
| -31% | -$127K |
|
1562
Travere Therapeutics
TVTX
$5.86B
| $268K | ﹤0.01% |
10,400
-4,600
| -31% | -$122K |
|
1563
CoreCivic
CXW
$3.32B
| $267K | ﹤0.01% |
23,900
| – | – |
|
1564
AMERISAFE
AMSF
$517M
| $266K | ﹤0.01% |
5,358
| – | – |
|
|
OTLY
1565
Oatly Group
OTLY
$420M
| $266K | ﹤0.01% |
2,650
| – | – |
|
|
CSII
1566
DELISTED
Cardiovascular Systems, Inc.
CSII
| $264K | ﹤0.01% |
11,700
| – | – |
|
1567
PAR Technology
PAR
$741M
| $262K | ﹤0.01% |
6,500
| – | – |
|
1568
Gibraltar Industries
ROCK
$1.46B
| $262K | ﹤0.01% |
6,109
-2,800
| -31% | -$148K |
|
1569
Repay Holdings
RPAY
$311M
| $261K | ﹤0.01% |
17,700
| – | – |
|
1570
Goosehead Insurance
GSHD
$2.33B
| $259K | ﹤0.01% |
3,300
| – | – |
|
1571
InMode
INMD
$876M
| $258K | ﹤0.01% |
7,000
| – | – |
|
|
ENDP
1572
DELISTED
Endo International plc
ENDP
| $258K | ﹤0.01% |
111,815
| – | – |
|
|
THS
1573
DELISTED
Treehouse Foods
THS
| $255K | ﹤0.01% |
7,909
-2,100
| -21% | -$79K |
|
|
ALX
1574
Alexander's
ALX
$1.39B
| $254K | ﹤0.01% |
993
| – | – |
|
1575
Relay Therapeutics
RLAY
$4.4B
| $254K | ﹤0.01% |
8,500
-5,400
| -39% | -$131K |
|
Similar funds
VIA
Handelsbanken Fonder's Q1 2022 Portfolio in Review
As of Q1 2022, Handelsbanken Fonder held 1,751 positions worth $17.9B, down 12% from $20.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Handelsbanken Fonder withdrew a net $772M in Q1 2022, closing 51 positions and reducing 786 holdings. Its most notable exit was IHS Markit Ltd. Common Shares, an estimated $13.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Handelsbanken Fonder opened a new position in Johnson Controls International worth $18.5M.
- Handelsbanken Fonder's largest Q1 2022 buy was Johnson Controls International: 282,551 shares worth $18.5M.
- Handelsbanken Fonder added most to Verra Mobility in Q1 2022, an estimated $34.1M increase.
- Handelsbanken Fonder's biggest Q1 2022 reduction was Livent Corporation, cutting an estimated $54.7M.
- Handelsbanken Fonder fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $13.8M.
- Handelsbanken Fonder's ten largest holdings make up 23% of its $17.9B portfolio in Q1 2022.
- Handelsbanken Fonder opened 15 new positions and closed 51 in Q1 2022.
- Handelsbanken Fonder's portfolio value fell 12% quarter-over-quarter to $17.9B.
Based on Handelsbanken Fonder's 13F filing for Q1 2022, filed 11 May 2022.